These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27780922)

  • 1. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
    Lapa C; Reiter T; Kircher M; Schirbel A; Werner RA; Pelzer T; Pizarro C; Skowasch D; Thomas L; Schlesinger-Irsch U; Thomas D; Bundschuh RA; Bauer WR; Gärtner FC
    Oncotarget; 2016 Nov; 7(47):77807-77814. PubMed ID: 27780922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
    Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
    Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of
    Kaushik P; Patel C; Gulati GS; Seth S; Parakh N; Randeep Guleria ; Kumar R; Gupta P; Bal C
    Ann Nucl Med; 2021 Sep; 35(9):1058-1065. PubMed ID: 34125376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
    Bravo PE; Bajaj N; Padera RF; Morgan V; Hainer J; Bibbo CF; Harrington M; Park MA; Hyun H; Robertson M; Lakdawala NK; Groarke J; Stewart GC; Dorbala S; Blankstein R; Di Carli MF
    J Nucl Cardiol; 2021 Jun; 28(3):1089-1099. PubMed ID: 31197742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis.
    Pizarro C; Kluenker F; Dabir D; Thomas D; Gaertner FC; Essler M; Grohé C; Nickenig G; Skowasch D
    ESC Heart Fail; 2018 Apr; 5(2):249-261. PubMed ID: 29231290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
    Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
    J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A; Pawar S; Govender P; Berman J; Ruberg FL; Miller EJ
    J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: A feasibility study.
    Aikawa T; Oyama-Manabe N; Naya M; Ohira H; Sugimoto A; Tsujino I; Obara M; Manabe O; Kudo K; Tsutsui H; Tamaki N
    Eur Radiol; 2017 Oct; 27(10):4054-4063. PubMed ID: 28382537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
    Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
    J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Kataoka S; Momose M; Fukushima K; Serizawa N; Suzuki A; Kondo C; Abe K; Sakai S; Hagiwara N
    Ann Nucl Med; 2017 Feb; 31(2):135-143. PubMed ID: 27804054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac metastases from neuroendocrine neoplasms: complementary role of SSTR PET/CT and cardiac MRI.
    Arnfield EG; Tam L; Pattison DA; Younger J; Chikatamarla VA; Wyld D; Burge M; McCormack L; Ladwa R; Ramsay S
    J Nucl Cardiol; 2023 Dec; 30(6):2676-2691. PubMed ID: 37587328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.